Dillon & Associates Inc. Has $12.73 Million Stake in Intuitive Surgical, Inc. $ISRG

Dillon & Associates Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,474 shares of the medical equipment provider’s stock after purchasing an additional 1,436 shares during the quarter. Intuitive Surgical makes up approximately 1.6% of Dillon & Associates Inc.’s portfolio, making the stock its 19th largest holding. Dillon & Associates Inc.’s holdings in Intuitive Surgical were worth $12,728,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also made changes to their positions in ISRG. IronOak Wealth LLC. acquired a new position in shares of Intuitive Surgical in the second quarter valued at $1,099,000. SteelPeak Wealth LLC increased its holdings in shares of Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock worth $18,781,000 after buying an additional 9,364 shares in the last quarter. Eastover Investment Advisors LLC raised its position in Intuitive Surgical by 204.8% in the 2nd quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock valued at $7,153,000 after purchasing an additional 8,844 shares during the last quarter. Amalgamated Bank raised its holdings in shares of Intuitive Surgical by 2.2% in the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after buying an additional 1,772 shares during the last quarter. Finally, Bessemer Group Inc. lifted its position in Intuitive Surgical by 89.3% during the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after buying an additional 371,806 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the transaction, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. The trade was a 81.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Craig H. Barratt sold 750 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $435,000.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 114,007 shares of company stock valued at $63,533,844 over the last 90 days. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 1.0%

Shares of NASDAQ ISRG opened at $541.34 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a market cap of $194.06 billion, a price-to-earnings ratio of 71.61, a P/E/G ratio of 4.44 and a beta of 1.67. The company’s fifty day moving average is $566.82 and its 200-day moving average is $512.30.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.84 EPS. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Preliminary Q4 and full‑year 2025 results beat expectations: procedure volume, system placements and revenue all grew, and management raised full‑year revenue guidance vs prior consensus—evidence of demand strength. Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results
• Positive Sentiment: Industry analysts reiterated buy/supportive views: Bernstein kept a Buy rating and William Blair reiterated bullish sentiment citing DV5 adoption and pipeline, which supports longer‑term growth expectations. Bernstein Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
• Positive Sentiment: Company commentary and industry coverage note da Vinci systems “exceeded expectations” in procedures and placements, underlining the platform’s commercial traction. Intuitive says daVinci systems ‘exceeded expectations,’ it wants more
• Neutral Sentiment: IS‑001 Phase 3 update (imaging‑driven safety product) is in progress — relevant for the pipeline but uncertain timing/impact on revenue; watch trial readouts. IS-001 Phase 3 Update
• Neutral Sentiment: da Vinci 5 international rollout is expanding but faces pricing, budget and reimbursement hurdles overseas — a mixed catalyst: growth potential but adoption risk outside the U.S. da Vinci 5 Expands Globally
• Negative Sentiment: Management set a softer 2026 outlook and lowered its expected da Vinci growth cadence for the year, which overshadowed the Q4 beat and prompted the pullback as investors re‑price growth expectations. Intuitive Surgical Sets Softer 2026 Outlook
• Negative Sentiment: Market reaction focused on a missed/tepid 2026 da Vinci growth projection despite solid quarterly results — traders viewed this as evidence of near‑term deceleration. da Vinci Growth Projection Misses Expectations
• Negative Sentiment: Commentary across outlets: “shares fell despite beating Q4” highlights investor sensitivity to forward guidance and valuation (high PE multiple); this sentiment amplified the decline. Why Intuitive Surgical Stock Is Falling Today

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ISRG. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Truist Financial raised their price objective on shares of Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a research note on Thursday, December 18th. Citigroup cut shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and dropped their target price for the company from $650.00 to $635.00 in a research report on Thursday, December 11th. Finally, Rothschild & Co Redburn raised their price target on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $622.17.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.